Pfizer, Valneva report strong efficacy data from Lyme vaccine trial
- Posted on March 23, 2026
- By Bing News
- 1 Views
Pfizer, Valneva report strong efficacy data from Lyme vaccine trial
Pharmaceutical giant Pfizer and French vaccine maker Valneva reported positive topline results from their phase three study of a vaccine candidate for Lyme disease.
